Altimmune Inc
Biotechnology
Healthcare
ALT
75.55 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
3.96
52 week high
9.85
high
3.97
52 week low
0.00
low
3.78
growth
-51.35 %
previous Close
3.96
P/E ratio
market cap
298 M
div yield
0
usd
Jun 2025
qoq
revenue
0.00 %
net incoming
0.00 %
eps
0.00 %
0.00 %
eps surprise
100.00 %
net profit margin
0.00 %
3915.00 %
operating incoming
0.00 %
net change in cash
0.00 %
cash on hand
0.00 %
cost of revenue
0.00 %
top top